25-hydroxyvitamin D

Subscribe to Selected New Research on 25-hydroxyvitamin D

553 relevant articles (13 outcomes, 60 trials/studies) found for this Bio-Agent

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 58

Steroids: 13691

Secosteroids: 3

Vitamin D: 7152

25-hydroxyvitamin D: 553

Experts

1.	Hollis, Bruce W: 10 articles (06/2008 - 04/2004)
2.	Giovannucci, Edward: 5 articles (06/2008 - 04/2004)
3.	Willett, Walter C: 4 articles (07/2007 - 04/2004)
4.	Bischoff-Ferrari, Heike A: 3 articles (05/2007 - 09/2005)
5.	Wu, Kana: 2 articles (06/2008 - 07/2007)
6.	Feskanich, Diane: 2 articles (06/2008 - 07/2007)
7.	Fuchs, Charles S: 2 articles (06/2008 - 07/2007)
8.	Giovannucci, Edward L: 2 articles (06/2008 - 07/2007)
9.	Soilu-Hänninen, M: 2 articles (02/2008 - 06/2005)
10.	Mononen, I: 2 articles (02/2008 - 06/2005)

Related Diseases

1.	Primary Hyperparathyroidism 12/01/1999 - "This study was performed to determine the prevalence in the United States of low 25-hydroxyvitamin D levels among patients with mild primary hyperparathyroidism, and the effect of 25-hydroxyvitamin D status on disease severity" 08/01/2006 - "BACKGROUND: Primary hyperparathyroidism (PHPT) is associated with reduced plasma 25-hydroxyvitamin D (P-25OHD) and usually increased plasma 1alpha,25-dihydroxyvitamin D (P-1,25(OH)2D)" 12/01/1987 - "2. The elimination half-time of 25-hydroxyvitamin D was significantly shortened in primary hyperparathyroidism and reverted towards normal after parathyroidectomy" 10/01/2008 - "Correlation of plasma 25-hydroxyvitamin D levels with severity of primary hyperparathyroidism and likelihood of parathyroid adenoma localization on sestamibi scan." 12/01/1987 - "4. Enhanced hepatic inactivation of 25-hydroxyvitamin D may be important in the development of vitamin D deficiency in primary hyperparathyroidism." Get all the results and reference details, order at left...
2.	Hypercalcemia (Milk Alkali Syndrome) 12/01/1986 - "Animals infused with 1,25-(OH)2D3 exhibited mild hypercalcemia (11.2 vs. 10.2 mg/dl in controls), a 136% increase in the serum concentration of 1,25-(OH)2D3 (187 vs. 79 pg/ml), and a 59% decrease in serum 25-hydroxyvitamin D (12 vs. 29 ng/ml)" 05/01/1981 - "The blood levels of 25-hydroxyvitamin D (25OHD3) were elevated during the hypercalcemia and decreased to normal when the patient became normocalcemic" 11/01/2006 - "Our previous cross-sectional study showed that immobilization-induced hypercalcemia (i.e., increased bone resorption) and 25-hydroxyvitamin D (25-OHD) deficiency contribute to reduced bone mineral density (BMD)" 03/01/2003 - "A third spell of hypercalcemia characterized by an acute rise in serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D to abnormally high levels occurred during the summer season after prolonged and intense exposure to the sun." 04/01/2000 - "We suggest that talc granulomatosis should be added to the list of granulomatous disorders capable of causing hypercalcemia due to increased extra-renal 1-alpha-hydroxylation of 25-hydroxyvitamin D." Get all the results and reference details, order at left...
3.	Hyperparathyroidism 08/08/2005 - "RESULTS: At baseline, patients of both groups showed 25-hydroxyvitamin D deficiency with compensatory hyperparathyroidism" 08/08/2005 - "We previously found that deficiency of 25-hydroxyvitamin D and compensatory hyperparathyroidism cause reduced bone mineral density in female patients with AD" 08/01/2005 - "We previously showed that 25-hydroxyvitamin D (25-OHD) deficiency caused by sunlight deprivation with compensatory hyperparathyroidism causes reduced BMD in elderly women with AD" 03/01/1983 - "Osteomalacia and hyperparathyroidism have been recently reported to occur as a consequence of those low levels of 25-hydroxyvitamin D (25OHD)" 06/01/2000 - "Ovx-induced exacerbation of hyperparathyroidism was confirmed by significantly greater conversion of 25-hydroxyvitamin D to 1, 25-dihydroxyvitamin D in ovx NA rats even after normalization to vitamin D-binding protein" Get all the results and reference details, order at left...
4.	Vitamin D Deficiency 02/01/2006 - "Measurement of serum total 25-hydroxyvitamin D concentration is the gold standard to diagnose vitamin D deficiency" 11/01/2006 - "RESULTS: In our total study population, prevalence of vitamin D deficiency, defined as a 25-hydroxyvitamin D concentration < 10 microg/L, was high (24%): one in eight Caucasians, one in four Black Afro-Caribbeans and one in three Asians were found to be deficient" 03/01/1995 - "The aim of this study was to measure 25-hydroxyvitamin D (25-(OH)D) levels and to search for biological signs of vitamin D deficiency during adolescence" 03/01/2008 - "Less than 1% of women had a 25-hydroxyvitamin D concentration indicative of vitamin D deficiency (<17.5 nmol/l); whereas, over 60% of women had a 25-hydroxyvitamin D concentration indicative of insufficiency (<50 nmol/l)" 05/01/2007 - "Various cutoff points of 25-hydroxyvitamin D were used to assess the prevalence of vitamin D deficiency (<9, <15, and <20 ng/mL)" Get all the results and reference details, order at left...
5.	Kidney Diseases (Kidney Disease) 07/01/2008 - "RESULTS: In study A, the adjusted odds for 25-hydroxyvitamin D deficiency were 32% higher in chronic kidney disease patients" 07/01/2008 - "BACKGROUND AND OBJECTIVES: Recent studies show high prevalence of suboptimal 25-hydroxyvitamin D levels in chronic kidney disease patients" 11/01/2006 - "25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease." 07/01/2005 - "Vigilance for maintaining a 25-hydroxyvitamin D level of at least 20 ng/ml and preferably 30-50 ng/ml has important benefits for both healthy children and adults, as well as children and adults suffering from chronic kidney disease." 09/01/2008 - "Recent observations have indicated that chronic kidney disease seems to be associated with a high incidence of nutritional vitamin D insufficiency or deficiency as manifested by decreased levels of 25-hydroxyvitamin D" Get all the results and reference details, order at left...
184 Diseases and 553 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Vitamin D
2.	hydroxide ion
3.	Parathyroid Hormone (Parathormone)
4.	Cholecalciferol (Vitamin D3)
5.	Calcium
6.	1,25-dihydroxyvitamin D
7.	Phosphorus (Red Phosphorus)
8.	Alkaline Phosphatase
9.	Vitamin D-Binding Protein
10.	Bilirubin
122 Drugs and Important Bio-Agents and 402 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Transplants (Transplant)
2.	Thyroidectomy
3.	Peritoneal Dialysis
4.	Bariatric Surgery
5.	Parathyroidectomy
16 Therapies and Procedures and 22 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>